Evidence map›Paper›PMID 21846838›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2011

Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI.

Jamie K Harrington, Halima Chahboune, Jason M Criscione, Alice Y Li, Narutoshi Hibino, Tai Yi, Gustavo A Villalona, Serge Kobsa, Dane Meijas, Daniel R Duncan and 5 more

Abstract readEvaluation Study
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Recent advances in artificial intelligent strategies for tissue engineering and regenerative medicine.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Review
  5. Hemodynamics and Wall Mechanics of Vascular Graft Failure.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  6. Tissue engineering: Relevance to neonatal congenital heart disease.Seminars in fetal & neonatal medicine · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Systematic Review of Tissue-Engineered Vascular Grafts.Frontiers in bioengineering and biotechnology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  16. Article
  17. The Heart and Great Vessels.Cold Spring Harbor perspectives in medicine · 2018
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jamie K HarringtonInterdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, CT 06510, USA.
Halima Chahboune
Jason M Criscione
Alice Y Li
Narutoshi Hibino
Tai Yi
Gustavo A Villalona
Serge Kobsa
Dane Meijas
Daniel R Duncan
Lesley Devine
Xenophon Papademetri
Toshiharu Shin'oka
Tarek M Fahmy
Christopher K Breuer

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Mechanisms of Vascular Neotissue Formation In Tissue Engineered Vascular GraftsR01HL098228 · NHLBI · YALE UNIVERSITY · PI BREUER, CHRISTOPHER KANE · 2010 to 2018
$3.6M
Development of Second Generation Tissue Engineered Vascular GraftsK08HL083980 · NHLBI · YALE UNIVERSITY · PI BREUER, CHRISTOPHER KANE · 2006 to 2010
$666k
CIHRHoward Hughes Medical InstituteNCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1RR024139NHLBI NIH HHS K08 HL083980NHLBI NIH HHS K08HL083980NHLBI NIH HHS R01 HL098228NHLBI NIH HHS R01-HL098228
6 · The paper itself

Abstract

A major limitation of tissue engineering research is the lack of noninvasive monitoring techniques for observations of dynamic changes in single tissue-engineered constructs. We use cellular magnetic resonance imaging (MRI) to track the fate of cells seeded onto functional tissue-engineered vascular grafts (TEVGs) through serial imaging. After in vitro optimization, murine macrophages were labeled with ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles and seeded onto scaffolds that were surgically implanted as inferior vena cava interposition grafts in SCID/bg mice. Serial MRI showed the transverse relaxation times (T(2)) were significantly lower immediately following implantation of USPIO-labeled scaffolds (T(2) = 44 ± 6.8 vs. 71 ± 10.2 ms) but increased rapidly at 2 h to values identical to control implants seeded with unlabeled macrophages (T(2) = 63 ± 12 vs. 63 ± 14 ms). This strongly indicates the rapid loss of seeded cells from the scaffolds, a finding verified using Prussian blue staining for iron containing macrophages on explanted TEVGs. Our results support a novel paradigm where seeded cells are rapidly lost from implanted scaffolds instead of developing into cells of the neovessel, as traditionally thought. Our findings confirm and validate this paradigm shift while demonstrating the first successful application of noninvasive MRI for serial study of cellular-level processes in tissue engineering.

Indexed as

Blood Vessel ProsthesisTissue EngineeringAnimalsCell LineCell SurvivalMacrophagesMagnetic Resonance ImagingMagnetite NanoparticlesMiceMice, SCIDTissue ScaffoldsVena Cava, InferiorMagnetite Nanoparticles

Identifiers

PMID21846838
PMCPMC3236630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.